rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lawrence Lamb

EVP and CSO

Company insider

Files Form 4 as: EVP and CSO, IN8bio.

In numbers

Trades disclosed
22
Buys
1
Sells
0
Bought
$999
Sold
$0
Companies
1
Companies where not an officer
0
First trade
29 Jul 2021
Last trade
9 May 2026
Last filed
12 May 2026

Companies traded

Where they are an officer
INAB IN8bioOfficer · Biotechnology · last 9 May 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 May 2026filed 12 May 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—54,000 at $0.00filing
9 May 2026filed 12 May 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—54,000 at $0.00filing
4 Feb 2026filed 6 Feb 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—72,000 at $0.00filing
4 Feb 2026filed 6 Feb 2026INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—72,000 at $0.00filing
27 Apr 2025filed 7 May 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code D—1,639filing
27 Apr 2025filed 7 May 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—1,639filing
5 Feb 2025filed 7 Feb 2025INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—306,750 at $0.00filing
19 Dec 2024filed 23 Dec 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—286,899 at $0.00filing
4 Sep 2024filed 5 Sep 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—250,000 at $0.00filing
7 Feb 2024filed 8 Feb 2024INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—169,000 at $0.00filing
13 Dec 2023filed 15 Dec 2023INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—1,639filing
13 Dec 2023filed 15 Dec 2023INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—1,639filing
13 Dec 2023filed 15 Dec 2023INAB IN8bioBiotechnologySEC FORM 4 Code A—1,639filing
21 Jun 2023filed 23 Jun 2023INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—77,600 at $0.00filing
14 Apr 2023filed 18 Apr 2023INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—200,000 at $0.00filing
21 Oct 2022filed 25 Oct 2022INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—62,826 at $0.00filing
16 Aug 2022filed 18 Aug 2022INAB IN8bioBiotechnologySEC FORM 4 Bought$999526 at $1.90filing
5 May 2022filed 9 May 2022INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code M—26,204 at $0.00filing
5 May 2022filed 9 May 2022INAB IN8bioBiotechnologySEC FORM 4 Code M$28K26,204 at $1.07filing
15 Feb 2022filed 17 Feb 2022INAB IN8biooption or derivative · BiotechnologySEC FORM 4 Code A—62,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Emily FairbairnDirector · Director at In8bio, filing Form 4 there in the last year
Jeremy R. GraffOfficer · Director at In8bio, filing Form 4 there in the last year
Peter C. BrandtDirector · Director at In8bio, filing Form 4 there in the last year
William Tai-Wei HoCEO · CEO at In8bio, filing Form 4 there in the last year
Corinne EpperlyDirector · Director at In8bio, filing Form 4 there in the last year